Innate Pharma SA announced that it has obtained 28.7 Million in non-dilutive financing in the form of two loans from Société Générale and BNP Paribas. The two loans have an initial term of one year with a five-year extension option. They are 90% guaranteed by the French state as part of the package of measures put in place by the French government to support companies during the COVID-19 pandemic.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 EUR | -1.86% | -9.64% | -19.47% |
Apr. 15 | Sanofi: progress in hematology trial | CF |
Apr. 15 | Innate Pharma: progress in hematology trial | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.47% | 185M | |
-1.40% | 41.35B | |
+41.93% | 40.38B | |
+3.66% | 39.05B | |
-12.11% | 26.67B | |
+2.12% | 24.07B | |
-23.70% | 18.36B | |
-3.37% | 11.68B | |
+21.55% | 11.6B | |
+7.99% | 11.15B |
- Stock Market
- Equities
- IPH Stock
- News Innate Pharma
- Innate Pharma S.A. Obtains €28.7 Million in Non-Dilutive Financing in the Form of State Guaranteed Loans